Organigram Global Inc.
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- James Hideo Yamanaka
- Full Time Employees
- 1,139
- Sector
- Process industries
- Industry
- Agricultural commodities/Milling
- Address
- 145 King Street West Toronto ON Canada M5H 1J8
- IPO Date
- Jan 5, 2012
- Website
- organigram.ca
- Similar Companies
- Business
- Organigram Holdings Inc. operates as a licensed cannabis producer primarily based in Moncton, New Brunswick, Canada. Founded in 2013, the company cultivates, processes, and distributes a broad portfolio of cannabis and cannabis-derived products across recreational and medical markets domestically, with expanding international reach. Its product offerings include dried flower, pre-rolls, milled flower, infused pre-rolls, cannabis edibles (such as gummies and chocolates), vaporizers (cartridges and disposable pens), concentrates and oils, and cannabis beverages. The company markets its products under multiple brands including SHRED, Holy Mountain, Big Bag O’ Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Boxhot, Edison JOLTS, Wola, Rizzlers, DEBUNK, Tremblant, and Laurentian. Its operations leverage advanced cultivation facilities with a three-tiered indoor growing system and automated manufacturing processes, ensuring consistent quality and compliance with Health Canada and international standards such as EU-GMP where applicable. In recent major developments, Organigram completed the acquisition of Motif Labs Ltd. in December 2024 for CAD 91.3 million, a strategic move generating significant cost synergies and strengthening its production capabilities. In early 2025, Organigram further expanded into the U.S. market through the acquisition of Collective Project, a hemp-derived THC beverage company, accelerating its entry into the fast-growing cannabinoid beverages segment with distribution now spanning 25 U.S. states and direct-to-consumer sales. The company also rebranded to Organigram Global Inc., reflecting a strategic emphasis on international expansion and market leadership in Canada. Leadership changes include the appointment of James Yamanaka as CEO in late 2025, reinforcing the company’s focus on growth and innovation. Organigram continues to emphasize innovation in product development, targeting diverse consumer segments across Canada, the U.S., and select international markets, including medical cannabis exports to countries like Australia, Germany, and Israel. Organigram operates primarily in the cannabis industry’s recreational and medical segments, serving provincial distributors, medical patients, adult recreational consumers, and international partners. Its headquarters are in Moncton, New Brunswick, and its product portfolio and operational capacity position it as a leading Canadian licensed producer with growing presence in the U.S. hemp-derived THC and international medical cannabis markets. The combination of acquired capabilities and brand portfolio diversity caters to value, mainstream, and premium market segments, supported by data-driven insights and scientific approaches to cannabis cultivation and product innovation to drive long-term growth. This comprehensive approach and strategic recent acquisitions position Organigram as a significant player in the global cannabis industry, diversifying its offerings and expanding its geographic footprint beyond Canada. The company's focus on innovation, quality, and market expansion drives its continued growth trajectory in a competitive industry landscape.
Company News
Organigram Provides Update on Integration of Sanity Group and Unified Global Operating Model
Head-To-Head Comparison: Organigram Global (NASDAQ:OGI) versus Avita Medical (NASDAQ:RCEL)
RxSight (NASDAQ:RXST) and Organigram Global (NASDAQ:OGI) Financial Survey
Organigram Global Inc. (OGI:CA) Discusses Strategic Priorities, Growth Initiatives, and Insights from Production Facilities Transcript
Organigram Global Targets Profitable Growth With Canada Focus and German Expansion
Organigram Global to Premiere The 2026 OG Investor Session Today at 4:00 p.m. ET on X
Reviewing Organigram Global (NASDAQ:OGI) & KORU Medical Systems (NASDAQ:KRMD)
Organigram Global to Host 2026 OG Investor Session
Organigram Global Accelerates Integration of Sanity Group Under Unified Global Operating Structure
Organigram Global Accelerates Integration of Sanity Group Under Unified Global Operating Structure
OrganiGram (OGI) Reports Q3 Loss, Beats Revenue Estimates
Organigram Global Q3 Earnings Call Highlights
Organigram Reports Record Third Quarter Fiscal 2026 Results
Organigram to Report Third Quarter Fiscal 2026 Results on August 11, 2026
Organigram Provides Business Update Highlighting Initial Sanity Performance and Canadian Market Share
Organigram: Record Harvests Are The Root Of Market Share Erosion
Organigram Global Inc. (OGI:CA) Q2 2026 Earnings Call Transcript
Organigram Says Vape Weakness Pressures Margins
OrganiGram (OGI) Reports Q2 Loss, Misses Revenue Estimates
Organigram Global Q2 Earnings Call Highlights